All Stories

  1. Pharmacokinetic and pharmacodynamic evaluation of daclatasvir, asunaprevir plus beclabuvir as a fixed-dose co-formulation for the treatment of hepatitis C
  2. Role of HLA-DP and HLA-DQ on the clearance of hepatitis B virus and the risk of chronic infection in a multiethnic population
  3. Clinical utility of pharmacogenomics in the management of hepatitis C
  4. Distribution of genetic polymorphisms associated with hepatitis C virus (HCV) antiviral response in a multiethnic and admixed population
  5. Human pegivirus molecular epidemiology in Argentina: Potential contribution of Latin American migration to genotype 3 circulation
  6. P9: Distribution of genetic polymorphisms associated to hepatitis C virus (HCV) antiviral response in a multiethnic and admixed population
  7. Genotypes B and C hepatocellular carcinoma–associated hepatitis B virus pre‐S mutants: their detection among F1b and A2 – but not F4 – isolates from Argentina
  8. Evolving Trends in the Hepatitis C Virus Molecular Epidemiology Studies: From the Viral Sequences to the Human Genome
  9. Naturally occurring hepatitis B virus (HBV) variants with primary resistance to antiviral therapy and S-mutants with potential primary resistance to adefovir in Argentina
  10. Detection of Hepatitis B Virus (HBV) Genotype E Carried--Even in the Presence of High Titers of Anti-HBs Antibodies--by an Argentinean Patient of African Descent Who Had Received Vaccination against HBV